Willem T. Ruifrok
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study.
Journal: JACC. Cardiovascular interventions
Published: May 24, 2024
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.
Journal: JACC. Cardiovascular interventions
Published: September 05, 2023
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Journal: Lancet (London, England)
Published: January 28, 2023
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Journal: European heart journal
Published: March 07, 2022
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise.
Journal: Pflugers Archiv : European journal of physiology
Published: February 01, 2021
The Alkmaar CTO Registry: A Retrospective Cohort Evaluating the Introduction of a Dedicated CTO Program.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: February 08, 2020
Galectin-3 increase in endurance athletes.
Journal: European journal of preventive cardiology
Published: June 01, 2013
Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia.
Journal: Cardiovascular research
Published: January 24, 2013
Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).
Journal: American heart journal
Published: December 30, 2012
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Journal: Circulation. Heart failure
Published: December 12, 2012
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Journal: The Journal of steroid biochemistry and molecular biology
Published: February 15, 2012
DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure.
Journal: European journal of heart failure
Published: December 07, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026